Ronne Yeo, Ph.D.
Vice President, Discovery
As founding member and VP of Discovery at Carmine, Ronne built and led the research team to create the REGENT™ Platform to enable RBCEV-mediated delivery of large nucleic acid payloads. The team subsequently demonstrated long-term expression and redosing of genetic cargo, providing proof-of-concept for Carmine’s innovative non-viral gene therapy platform. Ronne currently leads platform research teams in both the US and Singapore sites and is an inventor of Carmine’s key patents.
Prior to Carmine, Ronne accumulated 7 years of basic research and pre-clinical development experience on therapeutic EVs derived from mesenchymal stem cells. Ronne has co-authored 4 research articles and 12 review articles/book chapters related to this work. Ronne obtained his Ph.D. in Biological Sciences from the National University of Singapore.